Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

AVEO Pharmaceuticals Inc (AVEO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AVEO's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AVEO historical data, for real-time data please try another search
15.000 0.000    0.00%
19/01 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 14.990 / 15.000
  • Day's Range: 14.990 - 15.000
AVEO 15.000 0.000 0.00%

AVEO Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of AVEO Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
Industry
Sector
Employees

114

Equity Type

ORD

AVEO Pharmaceuticals, Inc., an oncology-focused biopharmaceutical company, focuses on developing and commercializing medicines for patients with cancer. It markets FOTIVDA, an oral, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC). The company is also developing tivozanib for the treatment of RCC, hepatocellular carcinoma, ovarian cancer, immunologically cold tumors, and cholangiocarcinoma. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in Phase II clinical trial for the treatment of head and neck squamous cell carcinoma, pancreatic cancer, and acute myeloid leukemia; AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; AV-203, a potent humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353 that targets the Notch 3 pathway. The company has collaborations and license agreements with AstraZeneca PLC; EUSA Pharma (UK) Limited; Biodesix, Inc.; CANbridge Life Sciences, Ltd.; Biogen Idec International GmbH; St. Vincent’s Hospital Sydney Limited; and Kyowa Kirin Co., Ltd. AVEO Pharmaceuticals, Inc. was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. The company was incorporated in 2001 and is based in Boston, Massachusetts. As of January 19, 2023, AVEO Pharmaceuticals, Inc. operates as a subsidiary of LG Chem, Ltd.

Contact Information

Address One Marina Park Drive 12th Floor
Boston, 02210
United States
Phone 857 400 0101
Fax 617 995 4995

Top Executives

Name Age Since Title
Jaywin Lee - 2023 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AVEO Comments

Write your thoughts about AVEO Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Patricia Belich
Patricia Belich Mar 24, 2021 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How far is this going to tank???
Carlos Andres
Carlos Andres Oct 04, 2020 8:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong??
Gene Emory
Gene Emory Nov 18, 2019 1:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Keep holding and buy lower to cost avg. 2020 will be big for this stock hitting new highs.
The Lost
The Lost Nov 18, 2019 1:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm interested, tell me why do you think that?
Eduardo Berrios
Eduardo Berrios Jun 03, 2019 11:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Unsure of when to sell. My avg is 0.84...1.00 maybe?
Paul Vezina
Paul Vezina Jun 03, 2019 11:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeah, I think Im gonna sell at 1, or just over.
Eduardo Berrios
Eduardo Berrios Jun 03, 2019 11:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Holding on to this one...
Eduardo Berrios
Eduardo Berrios Jun 03, 2019 11:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Holding on to this one...
MR gatsby
MR gatsby May 31, 2019 2:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.00
Paul Vezina
Paul Vezina May 31, 2019 2:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mark, you think sell at a buck?
MR gatsby
MR gatsby May 31, 2019 2:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
if you're conservative yes , but if you got edge iw old say around 1.05 - 1.25
MR gatsby
MR gatsby May 31, 2019 2:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
*I*would
hol pat
hol pat Sep 07, 2017 12:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is there a BO to JAZZ ongoing?16-19$
Naret Ong
Naret Ong Mar 14, 2017 6:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
9340
Jaime Calderon
Jaime Calderon Mar 14, 2017 6:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is that your 4 digit pin?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email